[1] The NHGRI GWAS Catalog. http://www.genome.gov/ gwastudies/.
[2] Cong L, Ran FA, Cox D, Lin SL, Barretto R, Habib N, Hsu PD, Wu XB, Jiang WY, Marraffini LA, Zhang F. Multiplex genome engineering using CRIPSR/Cas systems. Science , 2013, 339(6121): 819-823.
[3] Mali P, Yang LH, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM. RNA-Guided Human Genome Engineering via Cas9. Science , 2013, 339(6121): 823-826.
[4] Jinek M, East A, Cheng A, Lin S, Ma E, Doudna J. RNA-programmed genome editing in human cells. Elife, 2013, 2: e00471.
[5] Cho SW, Kim S, Kim JM, Kim JS. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol , 2013, 31(3): 230-232.
[6] Ding QR, Regan SN, Xia YL, Oostrom LA, Cowan CA, Musunuru K. Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs. Cell Stem Cell , 2013, 12(4): 393-394.
[7] Peters DT, Cowan CA, Musunuru K. Genome editing in human pluripotent stem cells. StemBook [Internet], 2013, Apr 29.
[8] Cowan CA, Klimanskaya I, McMahon J, Atienza J, Witmyer J, Zucker JP, Wang SP, Morton CC, McMahon AP, Powers D, Melton DA. Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med , 2004, 350(13): 1353-1356.
[9] Ding QR, Lee YK, Schaefer EAK, Peters DT, Veres A, Kim K, Kuperwasser N, Motola DL, Meissner TB, Hendriks WT, Trevisan M, Gupta RM, Moisan A, Banks E, Friesen M, Schinzel RT, Xia F, Tang A, Xia YL, Figueroa E, Wann A, Ahfeldt T, Daheron L, Zhang F, Rubin LL, Peng LF, Chung RT, Musunuru K, Cowan CA. A TALEN genome-editing system for generating human stem cell-based disease models. Cell Stem Cell , 2013, 12(2): 238-251.
[10] Sun L, Goff LA, Trapnell C, Alexander R, Lo KA, Hacisuleyman E, Sauvageau M, Tazon-Vega B, Kelley DR, Hendrickson DG, Yuan BB, Kellis M, Lodish HF, Rinn JL. Long noncoding RNAs regulate adipogenesis. Proc Natl Acad Sci USA , 2013, 110(9): 3387-3392.
[11] Yu C, Liu YX, Ma TH, Liu K, Xu SH, Zhang Y, Liu HL, La Russa M, Xie M, Ding S, Qi LS. Small molecules enhance CRISPR genome editing in pluripotent stem cells. Cell Stem Cell , 2015, 16(2): 142-147.
[12] Chu VT, Weber T, Wefers B, Wurst W, Sander S, Rajewsky K, Kühn R. Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells. Nat Biotechnol , 2015, 33(5): 543-548.
[13] Maruyama T, Dougan SK, Truttmann MC, Bilate AM, Ingram JR, Ploegh HL. Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining. Nat Biotechnol , 2015, 33(5): 538-542.
[14] Canver MC, Bauer DE, Dass A, Yien YY, Chung J, Masuda T, Maeda T, Paw BH, OrkinSH. Characterization of genomic deletion efficiency mediated by CRISPR/Cas9 in mammalian cells. J Biol Chem , 2014, 289(31): 21312- 21324.
[15] Lee HJ, Kim E, Kim JS. Targeted chromosomal deletions in human cells using zinc finger nucleases. Genome Res , 2010, 20(1): 81-89.
[16] Lee HJ, Kweon J, Kim E, Kim S, Kim JS. Targeted chromosomal duplications and inversions in the human genome using zinc finger nucleases. Genome Res , 2012, 22(3): 539-548.
[17] Veres A, Gosis BS, Ding QR, Collins R, Ragavendran A, Brand H, Erdin S, Cowan CA, Talkowski ME, Musunuru K. Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing. Cell Stem Cell , 2014, 15(1): 27-30.
[18] Smith C, Gore A, Yan W, Abalde-Atristain L, Li Z, He CX, Wang Y, Brodsky RA, Zhang K, Cheng LZ, Ye ZH. Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs. Cell Stem Cell , 2014, 15(1): 12-13.
[19] Suzuki K, Yu C, Qu J, Li M, Yao XT, Yuan TT, Goebl A, Tang SW, Ren RT, Aizawa E, Zhang F, Xu XL, Soligalla RD, Chen F, Kim J, Kim NY, Liao HK, Benner C, Esteban CR, Jin YB, Liu GH, Li YR, Izpisua Belmonte JC. Targeted gene correc
